NASDAQ · Analyst Forecast

XORTX Therapeutics Inc. (XRTX) Stock Forecast & Price Target

$1.06 NASDAQ: XRTX Market Cap $1.93M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering XORTX Therapeutics Inc. (XRTX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For XORTX Therapeutics Inc., analysts forecast revenue falling from $84.40M in 2023 to $16.00M in 2027; the average estimate for 2027 earnings per share is $4.00; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2023$84.40M$84.40M$84.40M1
2024$2.65M$2.65M$2.65M1
2025$128.76M$128.76M$128.76M1
2026$3.25M$3.25M$3.25M1
2027$16.00M$16.00M$16.00M1

Earnings per share forecast

YearLowAverageHighAnalysts
2023−$2.81−$2.81−$2.811
2024−$7.50−$7.50−$7.501
2025−$3.45−$3.45−$3.451
2026−$1.75−$1.75−$1.751
2027$4.00$4.00$4.001

XORTX Therapeutics Inc. (XRTX) forecast — frequently asked questions

What are analysts forecasting for XORTX Therapeutics Inc.'s earnings?

The average analyst estimate for XORTX Therapeutics Inc. (XRTX) earnings per share in 2027 is 4.00, with individual estimates between 4.00 and 4.00.

How much revenue is XORTX Therapeutics Inc. expected to make?

Analysts forecast XORTX Therapeutics Inc. (XRTX) revenue of $16.00M in 2027, based on 1 published estimates.

How many analysts cover XRTX?

1 analyst contribute estimates for XORTX Therapeutics Inc. (XRTX). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.